Low-Frequency Low-Intensity Ultrasounds Do Not Influence the Survival and Immune Functions of Cultured Keratinocytes and Dendritic Cells

Low-frequency ultrasounds (US) are used to enhance drug transdermal transport. Although this phenomenon has been extensively analyzed, information on US effects on the single skin cell components is limited. Here, we investigated the possible effects of low-frequency US on viability and immune functions of cultured human keratinocytes and dendritic cells (DC), skin cells involved in the regulation of many immune-mediated dermatoses. We demonstrated that US, employed at low-frequency (42 KHz) and low-intensity (0.15 W/cm2) values known to enhance drug and water transdermal transport, did not affect extracellular-signal-regulated-kinase (ERK)1/2 activation, cell viability, or expression of adhesion molecules in cultured keratinocytes. Moreover, US at these work frequency and intensity did not influence the keratinocyte expression and release of immunomodulatory molecules. Similarly, cultured DC treated with low-frequency low-intensity US were viable, and did not show an altered membrane phenotype, cytokine profile, nor antigen presentation ability. However, intensity enhancement of low-frequency US to 5 W/cm2 determined an increase of the apoptotic rate of both keratinocytes and DC as well as keratinocyte CXCL8 release and ERK1/2 activation, and DC CD40 expression. Our study sustains the employment of low-frequency and low-intensity US for treatment of those immune skin disorders, where keratinocytes and DC have a pathogenetic role.

[1]  U. Siegenthaler,et al.  Studies on contact sensitivity to chromium in the guinea pig. The role of valence in the formation of the antigenic determinant. , 1983, The Journal of investigative dermatology.

[2]  Adrian C. Williams,et al.  Penetration enhancers. , 2004, Advanced drug delivery reviews.

[3]  C. Albanesi,et al.  Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. , 2007, Clinics in dermatology.

[4]  M. Pittelkow,et al.  Physiological effects of ultrasound mist on fibroblasts , 2007, International journal of dermatology.

[5]  R. Callard,et al.  Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. , 2004, European journal of immunology.

[6]  C. Albanesi,et al.  Cross-linking of membrane CD43 mediates dendritic cell maturation. , 1999, Journal of immunology.

[7]  J. Kushner,et al.  Heterogeneity in skin treated with low-frequency ultrasound. , 2008, Journal of pharmaceutical sciences.

[8]  J. Weaver,et al.  A quantitative study of electroporation showing a plateau in net molecular transport. , 1993, Biophysical journal.

[9]  Mark G. Allen,et al.  Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Tachibana,et al.  Scanning electron microscopic evaluation of the skin surface after ultrasound exposure , 1997, The Anatomical record.

[11]  Samir Mitragotri,et al.  Transdermal Drug Delivery Using Low-Frequency Sonophoresis , 2004, Pharmaceutical Research.

[12]  P. Elias,et al.  Epidermal lipids, barrier function, and desquamation. , 1983, The Journal of investigative dermatology.

[13]  F. Tanzi,et al.  A new sonographic method for the evaluation of skin permeability changes after irradiation with low-frequency ultrasound , 2007, SPIE Medical Imaging.

[14]  H. Yardley.  Epidermal lipids , 1987, International journal of cosmetic science.

[15]  F Patat,et al.  Clinical, histologic, and electron microscopy study of skin exposed to low‐frequency ultrasound , 2001, The Anatomical record.

[16]  S. Mitragotri,et al.  Low-frequency ultrasound as a transcutaneous immunization adjuvant. , 2005, Vaccine.

[17]  S. Mitragotri,et al.  Ultrasound-mediated transdermal protein delivery , 1995, Science.

[18]  G. Pellegrini,et al.  Role of Integrins in Cell Adhesion and Polarity in Normal Keratinocytes and Human Skin Pathologies , 1994, The Journal of dermatology.

[19]  S. Mitragotri,et al.  Ultrasound-induced cavitation: applications in drug and gene delivery , 2006, Expert opinion on drug delivery.

[20]  G. Girolomoni,et al.  ERK1/2 Regulates Epidermal Chemokine Expression and Skin Inflammation1 , 2005, The Journal of Immunology.

[21]  K. Tachibana,et al.  Transdermal delivery of insulin by ultrasonic vibration , 1991, The Journal of pharmacy and pharmacology.

[22]  Seung Hun Lee,et al.  Iontophoresis and sonophoresis stimulate epidermal cytokine expression at energies that do not provoke a barrier abnormality: lamellar body secretion and cytokine expression are linked to altered epidermal calcium levels. , 2003, The Journal of investigative dermatology.

[23]  Nadine Barrie Smith,et al.  Ultrasound-mediated transdermal transport of insulin in vitro through human skin using novel transducer designs. , 2003, Ultrasound in medicine & biology.

[24]  C. Albanesi,et al.  Keratinocytes in inflammatory skin diseases. , 2005, Current drug targets. Inflammation and allergy.

[25]  S. Mitragotri,et al.  Topical Delivery of Anti-sense Oligonucleotides Using Low-Frequency Sonophoresis , 2004, Pharmaceutical Research.

[26]  Giampiero Girolomoni,et al.  Impaired IFN-γ-Dependent Inflammatory Responses in Human Keratinocytes Overexpressing the Suppressor of Cytokine Signaling 11 , 2002, The Journal of Immunology.

[27]  T J Flotte,et al.  Photomechanical transcutaneous delivery of macromolecules. , 1998, The Journal of investigative dermatology.

[28]  S. Mitragotri,et al.  Low-frequency sonophoresis: a review. , 2004, Advanced drug delivery reviews.

[29]  Susan Gibbs,et al.  Dendritic cells: biology of the skin , 2009, Contact dermatitis.

[30]  A. Stalder,et al.  Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin , 1997, Experimental dermatology.